Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Jazz Pharmaceuticals plc

http://jazzpharma.com

Latest From Jazz Pharmaceuticals plc

Finance Watch: Patient Square Capital Raises Mega-Fund, Topping Out At $3.9bn

Private Company Edition: Patient Square’s private equity fund, which surpassed its $3bn fundraising goal, may invest broadly across health care but the firm already has invested heavily in biopharma. Also, investor Dimension launches with a $350m specialized VC fund and Alto increased its series B to $60m.

Financing Innovation

FDA Urged To Collaborate With USPTO On Orange Book Listings, Eliminate Patent Use Codes

Stakeholders suggest a variety of USPTO and FDA actions that could help ensure patents do not improperly delay generic and biosimilar competition.

Intellectual Property Legal Issues

Who’s Hired? Nichi-Iko Looks To Sandoz For Fresh Leadership

Nichi-Iko has revealed its choice of new leadership, looking to Sandoz Japan for its next president and CEO. Meanwhile, Ethypharm and Krka have made fresh appointments in the UK and Centrient has named a new chief quality officer.

Executive Changes Leadership

End Of US FDA’s Very Fast Reviews? 2022 Novel Approvals Stayed Close To PDUFA Timeframes

Moderation was a theme of the year in novel approvals, as CDER’s median review time rose for the first time in five years and even the center’s fastest approval took more than seven months. A Pink Sheet infographic breaks down which review pathways did the best last year. 

Pink Sheet Perspectives US FDA Performance Tracker
See All

Company Information

  • Industry
  • Biotechnology
  • Contract Manufacturing Organization
  • Biotechnology
    • Drug Discovery Tools
  • Other Names / Subsidiaries
    • Alizé Pharma II
    • Azur Pharma Public Limited Company
    • Cavion, Inc.
    • Cavion LLC (Tau Therapeutics LLC
    • Xdynia LLC)
    • Celator Pharmaceuticals, Inc.
    • Gentium S.p.A.
    • GW Pharmaceuticals plc
    • Jazz Pharmaceuticals Ireland Limited
    • Orphan Medical, Inc.
UsernamePublicRestriction

Register